We are live on ! Find out more
ZIM

Zacks Investment Management Portfolio holdings

AUM $12.5B
1-Year Est. Return 29.36%
This Fund
S&P 500
This Quarter Est. Return
+18.29%
1 Year Est. Return
+29.36%
3 Year Est. Return
+98.03%
5 Year Est. Return
+139.15%
10 Year Est. Return
+465.5%
AUM
$4.55B
AUM Growth
+$471M
Cap. Flow
-$144M
Cap. Flow %
-3.17%
Top 10 Hldgs %
21.2%
Holding
610
New
118
Increased
118
Reduced
253
Closed
110

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$32.4M
2
CTVA icon
Corteva
CTVA
+$31.9M
3
PEG icon
Public Service Enterprise Group
PEG
+$26M
4
RTX icon
RTX Corp
RTX
+$12.1M
5
ABBV icon
AbbVie
ABBV
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Healthcare 15.06%
3 Financials 14.64%
4 Consumer Staples 10.68%
5 Consumer Discretionary 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGND icon
401
Ligand Pharmaceuticals
LGND
$6.36B
$443K 0.01%
+6,345
New +$402K
MCD icon
402
McDonald's
MCD
$195B
$434K 0.01%
2,355
+74
+3% +$13.6K
MGPI icon
403
MGP Ingredients
MGPI
$375M
$433K 0.01%
+11,804
New +$422K
SCHX icon
404
Schwab US Large- Cap ETF
SCHX
$74.6B
$431K 0.01%
+34,902
New +$407K
GLDD
405
DELISTED
Great Lakes Dredge & Dock
GLDD
$422K 0.01%
+45,572
New +$399K
HELE icon
406
Helen of Troy
HELE
$693M
$421K 0.01%
2,231
-8,377
-79% -$1.37M
RGEN icon
407
Repligen
RGEN
$9.25B
$421K 0.01%
+3,409
New +$401K
CCOI icon
408
Cogent Communications
CCOI
$508M
$417K 0.01%
+5,388
New +$436K
RBCAA icon
409
Republic Bancorp
RBCAA
$1.95B
$411K 0.01%
12,580
-19
-0.2% -$601
VRCA icon
410
Verrica Pharmaceuticals
VRCA
$87.3M
$411K 0.01%
3,733
-80
-2% -$9.25K
FRST icon
411
Primis Financial Corp
FRST
$404M
$409K 0.01%
42,171
ATEN icon
412
A10 Networks
ATEN
$1.95B
$408K 0.01%
59,847
GBT
413
DELISTED
Global Blood Therapeutics, Inc.
GBT
$404K 0.01%
+6,402
New +$439K
TNK icon
414
Teekay Tankers
TNK
$2.68B
$395K 0.01%
30,833
+1,800
+6% +$31.8K
SNA icon
415
Snap-on
SNA
$21.5B
$390K 0.01%
2,812
+89
+3% +$11.3K
EFA icon
416
iShares MSCI EAFE ETF
EFA
$80.2B
$388K 0.01%
6,381
+63
+1% +$3.64K
TCMD icon
417
Tactile Systems Technology
TCMD
$665M
$387K 0.01%
9,343
-5,796
-38% -$272K
HNGR
418
DELISTED
Hanger Inc.
HNGR
$386K 0.01%
23,315
+8,852
+61% +$150K
RAVN
419
DELISTED
Raven Industries Inc
RAVN
$383K 0.01%
17,822
-2,443
-12% -$51.6K
KRTX
420
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$374K 0.01%
+3,353
New +$292K
PANW icon
421
Palo Alto Networks
PANW
$297B
$371K 0.01%
9,702
CMRE icon
422
Costamare
CMRE
$1.77B
$366K 0.01%
65,773
-145,637
-69% -$710K
KNSA icon
423
Kiniksa Pharmaceuticals
KNSA
$5.93B
$363K 0.01%
+14,239
New +$297K
MRCY icon
424
Mercury Systems
MRCY
$6.52B
$359K 0.01%
+4,565
New +$374K
RCUS icon
425
Arcus Biosciences
RCUS
$3.64B
$352K 0.01%
+14,243
New +$384K

Similar funds

Zacks Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Zacks Investment Management held 610 positions worth $4.55B, up 12% from $4.08B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Zacks Investment Management withdrew a net $144M in Q2 2020, closing 110 positions and reducing 253 holdings. Its most notable exit was Steel Dynamics, an estimated $15.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Zacks Investment Management opened a new position in ConocoPhillips worth $33.6M.

  • Zacks Investment Management's largest Q2 2020 buy was ConocoPhillips: 800,504 shares worth $33.6M.
  • Zacks Investment Management added most to AbbVie in Q2 2020, an estimated $10.4M increase.
  • Zacks Investment Management's biggest Q2 2020 reduction was Ameriprise Financial, cutting an estimated $42.7M.
  • Zacks Investment Management fully exited Steel Dynamics in Q2 2020, selling an estimated $15.5M.
  • Zacks Investment Management's ten largest holdings make up 21% of its $4.55B portfolio in Q2 2020.
  • Zacks Investment Management opened 118 new positions and closed 110 in Q2 2020.
  • Zacks Investment Management's portfolio value rose 12% quarter-over-quarter to $4.55B.

Based on Zacks Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.